Home › Companies › Harvard Bioscience, Inc. › 2024-2025
At Harvard Bioscience, Inc.'s shareholder meeting held June 2, 2025, in the 2024-2025 proxy season, 96 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 488 separate fund positions. On the most widely held item on that ballot — Approval, by a non-binding advisory vote, of the compensation of the Company's named executive… — Harvard Bioscience, Inc.'s filing reports the proposal as approved, with 90% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Harvard Bioscience, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 2, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Harvard Bioscience, Inc.’s Form 8-K, filed June 2, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 2, 2025: 4 items on Harvard Bioscience, Inc.’s Form 8-K, filed June 2, 2025: 3 approved · 1 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore Harvard Bioscience, Inc. in the interactive database Compare manager voting policies
These tallies are Harvard Bioscience, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 2, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: James Green | 23,563,965 | -- | -- | 3,188,231 | 5,066,123 | 88% | Not verified | — |
| 2. Ratification of the Appointment of Grant Thornton LLP | 31,536,184 | 116,407 | 165,728 | -- | -- | 99.6% | Approved | — |
| 3. Approval, by Non-Binding Advisory Vote, of the Compensation of the Company's named executive officers | 23,840,892 | 2,542,426 | 368,878 | -- | 5,066,123 | 90% | Approved | — |
| 4. Approval of the Amended and Restated 2021 Incentive Plan | 25,144,481 | 1,370,420 | 237,295 | -- | 5,066,123 | 95% | Approved | — |
Source: Harvard Bioscience, Inc., Form 8-K, filed with the SEC on June 2, 2025 — read the filing on EDGAR.
Each item below shows how the 96 asset managers that disclosed a Harvard Bioscience, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
88% Majority: yes · of votes cast
Description as filed by funds: Election of Director: James W. Green
Harvard Bioscience, Inc.’s own tally for this item (“Elect Director: James Green”): 23,563,965 for, 3,188,231 withheld, per its Form 8-K filed June 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 8,540,936 for, 903,915 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,109,522 | 0 | 0 | 0 | For |
| Royce | 1,695,146 | 0 | 0 | 0 | For |
| BlackRock | 1,431,595 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 937,144 | 0 | 0 | 0 | For |
| Fidelity | 821,696 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 817,962 | Withhold |
| Jackson National | 453,803 | 0 | 0 | 10,682 | For |
| Victory Capital | 223,499 | 0 | 0 | 0 | For |
| TIAA | 139,999 | 0 | 0 | 0 | For |
| Charles Schwab | 98,883 | 0 | 0 | 0 | For |
| Equitable | 82,623 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 77,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 75,231 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 0 | 0 | 0 | 67,762 | Withhold |
| Northern Trust | 65,164 | 0 | 0 | 0 | For |
| Gabelli | 65,000 | 0 | 0 | 0 | For |
| GPS Funds I | 44,685 | 0 | 0 | 0 | For |
| Goldman Sachs | 41,643 | 0 | 0 | 0 | For |
| Lincoln Financial | 30,800 | 0 | 0 | 0 | For |
| Global X | 25,155 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,967 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 19,735 | 0 | 0 | 0 | For |
| State Street | 15,184 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,740 | 0 | 0 | 0 | For |
| Nationwide | 14,579 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: Approval of the Harvard Bioscience, Inc. Amended and Restated 2021 Incentive Plan to increase the number of authorized shares of Common Stock available for issuance thereunder.
Harvard Bioscience, Inc.’s own tally for this item (“4. Approval of the Amended and Restated 2021 Incentive Plan”): 25,144,481 for, 1,370,420 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4 – Approval of the Amended and Restated 2021 Incentive Plan The Company's stockholders approved the Amended and Restated 2021 Incentive Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,424,290 for, 70,992 against, 65,000 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,109,522 | 0 | 0 | 0 | For |
| Royce | 1,695,146 | 0 | 0 | 0 | For |
| BlackRock | 1,431,595 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 937,144 | 0 | 0 | 0 | For |
| Fidelity | 821,696 | 0 | 0 | 0 | For |
| Dimensional | 817,962 | 0 | 0 | 0 | For |
| Jackson National | 464,485 | 0 | 0 | 0 | For |
| Victory Capital | 223,499 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 115,431 | 67,762 | 0 | 0 | Mixed |
| TIAA | 139,999 | 0 | 0 | 0 | For |
| Charles Schwab | 98,883 | 0 | 0 | 0 | For |
| Equitable | 82,623 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 77,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 75,231 | 0 | 0 | 0 | For |
| Northern Trust | 65,164 | 0 | 0 | 0 | For |
| Gabelli | 0 | 0 | 65,000 | 0 | Abstain |
| GPS Funds I | 44,685 | 0 | 0 | 0 | For |
| Goldman Sachs | 41,643 | 0 | 0 | 0 | For |
| Lincoln Financial | 30,800 | 0 | 0 | 0 | For |
| Global X | 25,155 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,967 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 19,735 | 0 | 0 | 0 | For |
| State Street | 15,184 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,740 | 0 | 0 | 0 | For |
| Nationwide | 14,579 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
90% Approved · of votes cast
Description as filed by funds: Approval, by a non-binding advisory vote, of the compensation of the Company's named executive officers.
Harvard Bioscience, Inc.’s own tally for this item (“3. Approval, by Non-Binding Advisory Vote, of the Compensation of the Company's named executive officers”): 23,840,892 for, 2,542,426 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 –Approval, by Non-Binding Advisory Vote, of the Compensation of the Company's named executive officers The Company's stockholders approved the compensation of the Company's named executive officers by a non-binding advisory vote, as follows:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,109,522 | 0 | 0 | 0 | For |
| Royce | 1,695,146 | 0 | 0 | 0 | For |
| BlackRock | 1,431,595 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 937,144 | 0 | 0 | 0 | For |
| Fidelity | 821,696 | 0 | 0 | 0 | For |
| Dimensional | 0 | 817,962 | 0 | 0 | Against |
| Jackson National | 453,803 | 10,682 | 0 | 0 | For |
| Victory Capital | 223,499 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 115,431 | 67,762 | 0 | 0 | Mixed |
| TIAA | 139,999 | 0 | 0 | 0 | For |
| Charles Schwab | 98,883 | 0 | 0 | 0 | For |
| Equitable | 82,623 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 77,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 75,231 | 0 | 0 | 0 | For |
| Northern Trust | 65,164 | 0 | 0 | 0 | For |
| Gabelli | 65,000 | 0 | 0 | 0 | For |
| GPS Funds I | 44,685 | 0 | 0 | 0 | For |
| Goldman Sachs | 41,643 | 0 | 0 | 0 | For |
| Lincoln Financial | 30,800 | 0 | 0 | 0 | For |
| Global X | 25,155 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,967 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 19,735 | 0 | 0 | 0 | For |
| State Street | 15,184 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,740 | 0 | 0 | 0 | For |
| Nationwide | 14,579 | 0 | 0 | 0 | For |
Fund voting reports, all 37 managers: 8,661,897 for, 898,385 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Harvey Partners, LLC | 2,150,000 | 0 | 0 | 0 | For |
| BlackRock | 1,201,246 | 0 | 0 | 0 | For |
| Granahan Investment Management, LLC | 1,091,860 | 0 | 0 | 0 | For |
| HEARTLAND ADVISORS INC | 937,144 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 923,061 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 779,337 | 0 | 0 | 0 | For |
| State Street | 690,830 | 0 | 0 | 0 | For |
| Meros Investment Management, LP | 0 | 506,435 | 0 | 0 | Against |
| Renaissance | 336,020 | 0 | 0 | 0 | For |
| Northern Trust | 331,589 | 0 | 0 | 0 | For |
| Citadel | 231,758 | 0 | 0 | 0 | For |
| STRS OHIO | 206,700 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 171,496 | 0 | 0 | 0 | For |
| Nuveen | 139,999 | 0 | 0 | 0 | For |
| Dimensional | 0 | 139,040 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 132,825 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 122,235 | 0 | 0 | 0 | For |
| Charles Schwab | 98,883 | 0 | 0 | 0 | For |
| Two Sigma | 90,862 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 89,517 | 0 | 0 | 0 | For |
| Gabelli | 85,000 | 0 | 0 | 0 | For |
| Goldman Sachs | 44,932 | 0 | 0 | 0 | For |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 0 | 0 | 42,568 | 0 | Abstain |
| Vanguard | 36,161 | 0 | 0 | 0 | For |
| Fidelity | 23,061 | 0 | 0 | 0 | For |
Institutional-manager reports, all 71 managers: 10,107,680 for, 670,968 against, 42,568 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
Harvard Bioscience, Inc.’s own tally for this item (“2. Ratification of the Appointment of Grant Thornton LLP”): 31,536,184 for, 116,407 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 –Ratification of the Appointment of Grant Thornton LLP The Company's stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, as follows:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,444,851 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,109,522 | 0 | 0 | 0 | For |
| Royce | 1,695,146 | 0 | 0 | 0 | For |
| BlackRock | 1,431,595 | 0 | 0 | 0 | For |
| HEARTLAND GROUP INC | 937,144 | 0 | 0 | 0 | For |
| Fidelity | 821,696 | 0 | 0 | 0 | For |
| Dimensional | 817,962 | 0 | 0 | 0 | For |
| Jackson National | 464,485 | 0 | 0 | 0 | For |
| Victory Capital | 223,499 | 0 | 0 | 0 | For |
| TIAA | 139,999 | 0 | 0 | 0 | For |
| Charles Schwab | 98,883 | 0 | 0 | 0 | For |
| Equitable | 82,623 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 77,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 75,231 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 67,762 | 0 | 0 | 0 | For |
| Northern Trust | 65,164 | 0 | 0 | 0 | For |
| Gabelli | 65,000 | 0 | 0 | 0 | For |
| GPS Funds I | 44,685 | 0 | 0 | 0 | For |
| Goldman Sachs | 41,643 | 0 | 0 | 0 | For |
| Lincoln Financial | 30,800 | 0 | 0 | 0 | For |
| Global X | 25,155 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 19,967 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 19,735 | 0 | 0 | 0 | For |
| State Street | 15,184 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,740 | 0 | 0 | 0 | For |
| Nationwide | 14,579 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 44,213,746 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.77% |
| 2 | Royce | 3.83% |
| 3 | BlackRock | 3.24% |
| 4 | HEARTLAND GROUP INC | 2.12% |
| 5 | Fidelity | 1.86% |
| 6 | Dimensional | 1.85% |
| 7 | Jackson National | 1.05% |
| 8 | Victory Capital | 0.51% |
| 9 | FORUM FUNDS II | 0.41% |
| 10 | TIAA | 0.32% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Harvey Partners, LLC | 4.86% |
| 2 | BlackRock | 2.72% |
| 3 | Granahan Investment Management, LLC | 2.47% |
| 4 | HEARTLAND ADVISORS INC | 2.12% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.09% |
| 6 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 1.76% |
| 7 | State Street | 1.56% |
| 8 | Meros Investment Management, LP | 1.15% |
| 9 | Renaissance | 0.76% |
| 10 | Northern Trust | 0.75% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Weber Capital Management, LLC | 7.24% | 13G |
| B. Riley Asset Management, LLC | 6.65% | DEF14A |
| BlackRock | 6.38% | 13F |
| James Green | 5.52% | DEF14A |
| HARVEY PARTNERS, LLC | 4.95% | 13G |
| Vanguard Group | 4.84% | 13F |
| Dimensional Fund Advisors | 3.25% | 13F |
| Geode Capital | 2.09% | 13F |
| Renaissance Technologies | 2.00% | 13F |
| BroadOak Income Fund, L.P. | 1.83% | 13D |
Percentages above are of 44,213,746 shares outstanding, as reported by Harvard Bioscience, Inc. on its Form 10-Q dated May 5, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Harvard Bioscience, Inc.’s 10-Q dated May 5, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Harvard Bioscience, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page).
proxyvotesnow.com, “Harvard Bioscience (HBIO) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/harvard-bioscience-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.